Our remote monitoring technology has helped us build the world’s largest cardiac data network, making care more accurate, comprehensive and efficient.
Processing over 4 billion heartbeats a day
Monitoring over 1 Million patients per year
Each month more than 30,000 physicians refer patients to our products
Provided over 1 million reports to physicians with information for diagnosis and therapy management
Over 50,000 monitoring devices – 29 U.S. patents and 34 international patents issued
Over $300 million invested in the technology and service platform
Find product details, quick start guides and more at myheartmonitor.com.
Company Delivers Record Revenue and Adjusted EBITDA Exceeds Expectations
February 22, 2018
BioTelemetry, Inc. (NASDAQ:BEAT) will release its fourth quarter 2017 earnings on Thursday, February 22nd at 4:00 PM Eastern Time.
February 12, 2018
BioTelemetry, Inc. (NASDAQ:BEAT), the leading mobile and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today a partnership with Apple (NASDAQ:AAPL) to provide cardiac monitoring services in conjunction with the Apple Heart Study.
November 30, 2017